Selected article for: "absence presence and cardiovascular disease"
Author: Agarwal, Manyoo A.; Ziaeian, Boback; Lavie, Carl J.; Fonarow, Gregg C.
Title: Cardiovascular Disease in Hospitalizations With a Diagnosis of Coronavirus From Pre-COVID-19 Era in United States: National Analysis From 2016-2017
  • Cord-id: 14tee5lz
  • Document date: 2020_9_22
    • ID: 14tee5lz
    Snippet: Objective To analyze the cardiovascular disease (CVD) burden in hospitalized patients with a diagnosis of coronavirus from pre-COVID-19 era in United States (US). Patients and Methods We identified adult hospitalizations with a diagnosis of coronavirus in a large US administrative database, National (Nationwide) Inpatient Sample (January 1, 2016 to December 3, 2017) to study patient demographics, clinical comorbidities and outcomes (in-hospital mortality and healthcare resource utilization) base
    Document: Objective To analyze the cardiovascular disease (CVD) burden in hospitalized patients with a diagnosis of coronavirus from pre-COVID-19 era in United States (US). Patients and Methods We identified adult hospitalizations with a diagnosis of coronavirus in a large US administrative database, National (Nationwide) Inpatient Sample (January 1, 2016 to December 3, 2017) to study patient demographics, clinical comorbidities and outcomes (in-hospital mortality and healthcare resource utilization) based upon presence or absence of CVD. Results A total of 21,300 adult hospitalizations with a diagnosis of coronavirus from 2016 to 2017 all across US were included in the final analysis; the mean age was 63.6 years, 51.8% were female and 74.7% public insurers. Among these, 11,930 hospitalizations (56.0%) had a diagnosis of CVD. Compared with those without CVD, hospitalizations with CVD were older (age, 70.1 vs. 55.4 years), had higher Charlson comorbidity score (2.5 vs. 1.6) and Elixhauser comorbidity index (4.3 vs. 2.4) (all p<.001). After multivariable risk adjustment, hospitalizations with CVD had higher mortality than those without CVD (5.3% vs. 1.5%; adjusted odds ratio = 2.0, 95% CI 1.2 to 3.4, p=.008). The mean length of stay (6.9 vs. 6.1 days, p=.003), hospital charges (78,377 vs. 66,538 US dollars, p=.002) and discharge disposition to nursing home was higher in those with CVD (24.6% vs. 12.9%, p<.001) when compared to no-CVD group. Conclusion: CVD was present in a significant proportion of hospitalizations with coronavirus in pre-COVID-19 era in US and was associated with higher risk of in-hospital mortality and healthcare resource utilization.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • absence presence and administrative database: 1
    • absence presence and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and long term outcome: 1, 2
    • absence presence and los angeles: 1, 2, 3
    • absence presence and los stay length: 1, 2, 3
    • acute pulmonary embolism and administrative database: 1, 2
    • acute pulmonary embolism and liver disease: 1, 2, 3, 4
    • acute pulmonary embolism and logistic regression: 1, 2, 3, 4
    • acute pulmonary embolism and long term outcome: 1
    • acute pulmonary embolism and los stay length: 1
    • acute respiratory failure and administrative database: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory failure and admission month: 1, 2, 3
    • acute respiratory failure and liver disease: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory failure and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory failure and long term outcome: 1, 2, 3, 4, 5
    • acute respiratory failure and los stay length: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • additional analysis and los stay length: 1